Published in Nucl Med Biol on October 22, 2009
Molecular imaging of microglia/macrophages in the brain. Glia (2012) 1.29
Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab (2012) 1.19
In vivo methods to study uptake of nanoparticles into the brain. Pharm Res (2010) 0.87
Reproducible Analysis of Rat Brain PET Studies Using an Additional [(18)F]NaF Scan and an MR-Based ROI Template. Int J Mol Imaging (2012) 0.84
Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis. Eur J Nucl Med Mol Imaging (2015) 0.81
Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers. Nucl Med Biol (2014) 0.77
Good clinical practice: historical background and key aspects. Nucl Med Commun (2005) 2.44
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med (2004) 2.22
Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging (2004) 2.21
Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med (2009) 2.17
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging. J Nucl Med (2009) 2.12
A large retrospective single-centre study to define the best image acquisition protocols and interpretation criteria for white blood cell scintigraphy with ⁹⁹mTc-HMPAO-labelled leucocytes in musculoskeletal infections. Eur J Nucl Med Mol Imaging (2013) 2.04
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. J Nucl Med (2007) 1.79
Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol (2006) 1.58
188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med (2005) 1.52
Nuclear medicine asleep in sleep research? Eur J Nucl Med Mol Imaging (2002) 1.45
[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol Imaging Biol (2009) 1.43
Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction. Eur J Nucl Med Mol Imaging (2013) 1.43
The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol (2012) 1.33
VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment. Cancer Res (2010) 1.27
89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922. J Nucl Med (2010) 1.23
Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys (2012) 1.19
The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol (2013) 1.13
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab (2009) 1.11
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther (2002) 1.11
PET imaging of oestrogen receptors in patients with breast cancer. Lancet Oncol (2013) 1.10
Phosphoramidite accelerated copper(i)-catalyzed [3 + 2] cycloadditions of azides and alkynes. Chem Commun (Camb) (2009) 1.10
PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma. J Nucl Med (2012) 1.10
Strain-promoted copper-free "click" chemistry for 18F radiolabeling of bombesin. Angew Chem Int Ed Engl (2011) 1.08
Multicenter harmonization of 89Zr PET/CT performance. J Nucl Med (2013) 1.07
Vertebral fracture assessment in supine position: comparison by using conventional semiquantitative radiography and visual radiography. Radiology (2009) 1.07
Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord (2013) 1.06
Functional imaging: where is the future? Hell J Nucl Med (2005) 1.06
PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. Curr Pharm Des (2008) 1.04
89Zr-bevacizumab PET imaging in primary breast cancer. J Nucl Med (2013) 1.03
Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. Clin J Am Soc Nephrol (2008) 1.02
Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol (2003) 1.00
Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus. Endocr Rev (2012) 0.98
Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2010) 0.98
Copper-free 'click': 1,3-dipolar cycloaddition of azides and arynes. Org Biomol Chem (2008) 0.96
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET. Eur J Nucl Med Mol Imaging (2006) 0.94
A comparison of micro-CT, microradiography and histomorphometry in bone research. Arch Oral Biol (2008) 0.94
Synthesis and preclinical evaluation of novel PET probes for P-glycoprotein function and expression. J Med Chem (2009) 0.94
The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord (2008) 0.94
Renal toxicity after radionuclide therapy. Radiat Res (2004) 0.93
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res (2009) 0.93
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis (2012) 0.92
[18F]FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging (2012) 0.92
18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers. Nucl Med Commun (2006) 0.90
Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation. Nucl Med Biol (2007) 0.90
Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings. Eur Neuropsychopharmacol (2012) 0.89
Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy. Eur J Nucl Med Mol Imaging (2002) 0.88
VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients. Eur J Cancer (2011) 0.88
Rise in extracellular fluid volume during high sodium depends on BMI in healthy men. Obesity (Silver Spring) (2009) 0.87
Clinical relevance of left ventricular volume assessment by gated myocardial SPET in patients with coronary artery disease. Eur J Nucl Med Mol Imaging (2002) 0.86
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med (2006) 0.86
Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings. Neurobiol Aging (2003) 0.86
Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer. World J Urol (2012) 0.86
Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. Acta Neurol Belg (2002) 0.85
Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: The TRAILS study. Schizophr Res (2011) 0.85
The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy. J Nucl Med (2005) 0.84
99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging (2004) 0.84
Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin. J Nucl Med (2007) 0.84
11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. J Nucl Med (2012) 0.84
Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats. J Psychopharmacol (2009) 0.84
Synthesis and optimization of the labeling procedure of 99mTc-HYNIC-interleukin-2 for in vivo imaging of activated T lymphocytes. Mol Imaging Biol (2009) 0.83
99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine. Nucl Med Commun (2004) 0.83
PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. Eur J Nucl Med Mol Imaging (2014) 0.83
The cholinergic system, sigma-1 receptors and cognition. Behav Brain Res (2010) 0.83
Thyroidal uptake and radiation dose after repetitive I-131-MIBG treatments: influence of potassium iodide for thyroid blocking. Med Pediatr Oncol (2002) 0.83
(99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model. Mol Pharm (2011) 0.83
Influence of the angle of incidence on the sensitivity of gamma camera based PET. Phys Med Biol (2002) 0.83
Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design. Neuroimage (2002) 0.82
Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study. Nucl Med Biol (2008) 0.82
The feasibility of repeated left ventricular ejection fraction analysis with sequential single-dose radionuclide ventriculography. Nucl Med Commun (2005) 0.82
In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Eur J Nucl Med Mol Imaging (2014) 0.82
Reduction of artefacts caused by hip implants in CT-based attenuation-corrected PET images using 2-D interpolation of a virtual sinogram on an irregular grid. Eur J Nucl Med Mol Imaging (2011) 0.82
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice. Mol Pharm (2012) 0.82
(111)In-trastuzumab scintigraphy in HER2-positive metastatic breast cancer patients remains feasible during trastuzumab treatment. Mol Imaging (2014) 0.81
123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Eur J Nucl Med Mol Imaging (2006) 0.81
Decreased 5-HT2a receptor binding in patients with anorexia nervosa. J Nucl Med (2003) 0.81
Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells. J Nucl Med (2006) 0.81
Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis. Eur J Nucl Med Mol Imaging (2015) 0.81
In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. J Nucl Med (2005) 0.81
Radionuclide detection of peritoneovenous shunt patency. Clin Nucl Med (2003) 0.81
Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulation. J Nucl Med (2008) 0.81
Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity. Bioconjug Chem (2010) 0.81
Use of gated 13N-NH3 micro-PET to examine left ventricular function in rats. Nucl Med Biol (2012) 0.81
Breast cancer: a new imaging approach as an addition to existing guidelines. Eur J Nucl Med Mol Imaging (2015) 0.80
Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression. Mol Imaging Biol (2011) 0.80
Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses. Biomark Med (2015) 0.80